What Happened?
Palo Alto, CA-based MapLight-Therapeutics Appointed Chris Kroeger as Chief Executive Officer
About the Company
MapLight Therapeutics is developing targeted, highly effective therapeutics to improve the lives of those with difficult-to-treat brain disorders. Today, there are few therapeutic options for people living with conditions such as schizophrenia, Alzheimer`s disease, Parkinson`s, and autism spectrum disorder. Available treatments are limited by modest efficacy and significant side effects. MapLight is committed to redefining this standard of care. The company`s unique discovery platform combines novel, proprietary technologies to uncover the individual circuits that misfire in brain disorders and treat those circuits with effective, safe therapeutics. MapLight was founded in 2019 by a team of renowned neuroscientists who led the discovery of the two groundbreaking technologies, optogenetics and STARmap.
About the Person
Chris Kroeger is Chief Executive Officer at MapLight Therapeutics. Previously, Chris held various senior HR leadership roles in the industry.
Info Source
News
Short Profile